We are live on
!
Find out more
IMNP
Immune Pharmaceuticals Inc.
IMNP
IMNP
Delisted
IMNP was delisted on the 25th of July, 2018.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
PRCM
1
Pine River Capital Management
Minnetonka,
Minnesota
| $653K | +$890K | +12,500 | New |
|
| 2 |
EEG
2
E.E. Geduld
| $134K | +$142K | +2,000 | New |
|
| 3 |
3
Goldman Sachs
New York
| $105K | +$111K | +1,557 | New |
|
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $75K | +$80K | +1,123 | New |
|
| 5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $67K | +$71.2K | +1,000 | New |
|
| 6 |
BPCE
6
Bank Pictet & Cie (Europe)
Frankfurt Am Main,
Germany
| $45K | +$45.9K | +645 | New |
|
| 7 |
SIM
7
Spark Investment Management
New York
| $36K | +$40.9K | +575 | New |
|
| 8 |
8
Morgan Stanley
New York
| $35K | +$36.3K | +510 | New |
|
| 9 |
TRCT
9
Tower Research Capital (TRC)
New York
| $3K | +$3.13K | +44 | New |
|